FUNDING◐ DEVELOPINGI · Intelligence◆ Concentrating
Chai Discovery raises $400M as AI antibodies enter pharma
Jul 14, 2026SOURCE: siliconangle.com
SO WHAT
The window is still open, but the value is shifting toward whoever owns the models, not just the lab bench.
Chai Discovery closed a $400 million Series C as its AI-designed antibodies reach Big Pharma. The signal is clear: intelligence is moving from assistive tool to source of drug design itself.
This is Negative Resistance’s reframed reading of a reported signal. The headline and analysis above are our interpretation through the thousand-day-window lens. The original reporting lives at the source linked above.